1. 297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study. (4th December 2020) Authors: Gonzalez-Martin, Antonio; Chung, Hyun Cheol; Saada-Bouzid, Esma; Yanez, Eduardo; Senellart, Hélène; Cassier, Philippe A; Basu, Bristi; Ghori, Razi; Kubiak, Peter; Smith, Alan; Norwood, Kevin; Lwin, Zarnie Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study. Issue 7 (July 2021) Authors: Lee, Chung-Han; Shah, Amishi Yogesh; Rasco, Drew; Rao, Arpit; Taylor, Matthew H; Di Simone, Christopher; Hsieh, James J; Pinto, Alvaro; Shaffer, David R; Girones Sarrio, Regina; Cohn, Allen Lee; Vogelzang, Nicholas J; Bilen, Mehmet Asim; Gunnestad Ribe, Sara; Goksel, Musaberk; Tennøe, Øyvind Kroh... Journal: Lancet oncology Issue: Volume 22:Issue 7(2021) Page Start: 946 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Partial cation substitution reduces iodide ion transport in lead iodide perovskite solar cells. Issue 7 (23rd May 2019) Authors: Ferdani, Dominic W.; Pering, Samuel R.; Ghosh, Dibyajyoti; Kubiak, Peter; Walker, Alison B.; Lewis, Simon E.; Johnson, Andrew L.; Baker, Peter J.; Islam, M. Saiful; Cameron, Petra J. Journal: Energy & environmental science Issue: Volume 12:Issue 7(2019) Page Start: 2264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗